Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 38651 - 38675 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Entinostat	Investigational	STK32A	202374	downregulated	entinostat results in decreased expression of STK32A mRNA	5q32	A21037
Entinostat	Investigational	STK40	83931	downregulated	entinostat results in decreased expression of STK40 mRNA	1p34.3	A21035
Entinostat	Investigational	STMN4	81551	downregulated	entinostat results in decreased expression of STMN4 mRNA	8p21.2	A21035
Entinostat	Investigational	STOX1	219736	downregulated	entinostat results in decreased expression of STOX1 mRNA	10q22.1	A21037
Entinostat	Investigational	STPG1	90529	upregulated	entinostat results in increased expression of STPG1 mRNA	1p36.11	A21035
Entinostat	Investigational	STRA6	64220	upregulated	entinostat results in increased expression of STRA6 mRNA	15q24.1	A21037
Entinostat	Investigational	STRN	6801	downregulated	entinostat results in decreased expression of STRN mRNA	2p22.2	A21037
Entinostat	Investigational	STX17	55014	downregulated	entinostat results in decreased expression of STX17 mRNA	9q31.1	A21037
Entinostat	Investigational	STYK1	55359	upregulated	entinostat results in increased expression of STYK1 mRNA	12p13.2	A21035
Entinostat	Investigational	SULF1	23213	downregulated	entinostat results in decreased expression of SULF1 mRNA	8q13.2-q13.3	A21037
Entinostat	Investigational	SULT1A1	6817	upregulated	entinostat results in increased expression of SULT1A1 mRNA	16p11.2	A21037
Entinostat	Investigational	SULT1A2	6799	upregulated	entinostat results in increased expression of SULT1A2 mRNA	16p11.2	A21037
Entinostat	Investigational	SULT1C2	6819	upregulated	entinostat results in increased expression of SULT1C2 mRNA	2q12.3	A21037
Entinostat	Investigational	SULT2B1	6820	upregulated	entinostat results in increased expression of SULT2B1 mRNA	19q13.3	A21035
Entinostat	Investigational	SUSD2	56241	upregulated	entinostat results in increased expression of SUSD2 mRNA	22q11.23	A21037
Entinostat	Investigational	SUSD3	203328	upregulated	entinostat results in increased expression of SUSD3 mRNA	9q22.31	A21037 A21035
Entinostat	Investigational	SVIL	6840	upregulated	entinostat results in increased expression of SVIL mRNA	10p11.23	A21035
Entinostat	Investigational	SVOPL	136306	upregulated	entinostat results in increased expression of SVOPL mRNA	7q34	A21037
Entinostat	Investigational	SWAP70	23075	upregulated	entinostat results in increased expression of SWAP70 mRNA	11p15.4	A21035
Entinostat	Investigational	SYK	6850	upregulated	entinostat results in increased expression of SYK mRNA	9q22.2	A21037
Entinostat	Investigational	SYNGR1	9145	upregulated	entinostat results in increased expression of SYNGR1 mRNA	22q13.1	A21037 A21035
Entinostat	Investigational	SYNGR2	9144	upregulated	entinostat results in increased expression of SYNGR2 mRNA	17q25.3	A21035
Entinostat	Investigational	SYNGR3	9143	upregulated	entinostat results in increased expression of SYNGR3 mRNA	16p13.3	A21035
Entinostat	Investigational	SYNJ2	8871	upregulated	entinostat results in increased expression of SYNJ2 mRNA	6q25.3	A21035
Entinostat	Investigational	SYNM	23336	upregulated	entinostat results in increased expression of SYNM mRNA	15q26.3	A21037

Displaying entries 38651 - 38675 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability